Hsbc Holdings PLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 43,615 shares of the company’s stock, valued at approximately $3,917,000. Hsbc Holdings PLC owned 0.05% of HealthEquity at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity during the fourth quarter valued at about $27,000. Aster Capital Management DIFC Ltd purchased a new stake in HealthEquity in the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd lifted its holdings in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the period. Leonteq Securities AG boosted its position in HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Silvant Capital Management LLC bought a new stake in HealthEquity during the 2nd quarter valued at approximately $35,000. 99.55% of the stock is currently owned by institutional investors.
Key HealthEquity News
Here are the key news stories impacting HealthEquity this week:
- Positive Sentiment: HealthEquity exceeded expectations with adjusted earnings of $1.24 per share versus the $1.19 consensus, while revenue reached $350.7 million, slightly above estimates. Revenue increased 95.5% year over year. HealthEquity Q2 Earnings and Revenues Top Estimates
- Positive Sentiment: Profitability improved, with net income rising 10% to $65.6 million and net margin expanding to 19% from 18%. Adjusted EBITDA grew 11% to $167 million, while its margin increased to 48% from 46%. HealthEquity Second-Quarter Financial Results
- Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $4.66–$4.73, above the $4.56 analyst consensus. Record HSA assets of $37.9 billion provide additional support for the company’s long-term growth outlook. HealthEquity Raises Fiscal 2027 Guidance
- Positive Sentiment: BTIG Research reaffirmed its “buy” rating and raised its price target to $115. Another analysis indicated that HQY could be approximately 19% undervalued after the guidance increase, reinforcing the bullish interpretation of the earnings update. BTIG Research Rating HealthEquity Could Be Undervalued
- Neutral Sentiment: Fiscal 2027 revenue guidance of approximately $1.4 billion was broadly in line with expectations, so the guidance improvement was driven mainly by stronger anticipated earnings and margins.
- Negative Sentiment: Director Adrian T. Dillon sold 7,632 shares valued at approximately $798,000, reducing his position by 10.9%. The sale was executed under a pre-arranged Rule 10b5-1 plan, which reduces its negative signaling value but could still attract investor attention. HealthEquity Director Stock Sale
- Negative Sentiment: HQY trades at a premium valuation of roughly 35 times earnings. After the recent advance toward its 52-week high, some investors may lock in gains, potentially tempering the stock’s reaction to otherwise favorable fundamentals.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on HQY
Insider Buying and Selling at HealthEquity
In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the business’s stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,456 shares of company stock worth $1,256,664 over the last three months. Corporate insiders own 1.60% of the company’s stock.
HealthEquity Price Performance
HQY stock opened at $96.37 on Friday. The firm has a 50 day moving average price of $98.16 and a 200-day moving average price of $87.87. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The firm has a market capitalization of $8.06 billion, a price-to-earnings ratio of 34.79, a PEG ratio of 1.62 and a beta of 0.21. The company has a debt-to-equity ratio of 0.47, a quick ratio of 3.44 and a current ratio of 2.99.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The company had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. The business’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
